CN104645149A - 一种治疗脊椎麻醉后头痛的中药组合物 - Google Patents
一种治疗脊椎麻醉后头痛的中药组合物 Download PDFInfo
- Publication number
- CN104645149A CN104645149A CN201510073675.3A CN201510073675A CN104645149A CN 104645149 A CN104645149 A CN 104645149A CN 201510073675 A CN201510073675 A CN 201510073675A CN 104645149 A CN104645149 A CN 104645149A
- Authority
- CN
- China
- Prior art keywords
- chinese medicine
- medicine composition
- radix
- headache
- spinal anesthesia
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 40
- 239000000203 mixture Substances 0.000 title claims abstract description 35
- 206010019233 Headaches Diseases 0.000 title claims abstract description 33
- 231100000869 headache Toxicity 0.000 title claims abstract description 33
- 238000002693 spinal anesthesia Methods 0.000 title claims abstract description 25
- 238000011282 treatment Methods 0.000 claims abstract description 22
- 241000218176 Corydalis Species 0.000 claims abstract description 14
- 241000255791 Bombyx Species 0.000 claims description 13
- 210000000582 semen Anatomy 0.000 claims description 13
- 239000002775 capsule Substances 0.000 claims description 11
- 229920002472 Starch Polymers 0.000 claims description 10
- 239000008107 starch Substances 0.000 claims description 10
- 235000019698 starch Nutrition 0.000 claims description 10
- 229940079593 drug Drugs 0.000 claims description 8
- 239000003795 chemical substances by application Substances 0.000 claims description 5
- -1 absorption carrier Substances 0.000 claims description 4
- 238000010521 absorption reaction Methods 0.000 claims description 4
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 claims description 4
- 239000011230 binding agent Substances 0.000 claims description 4
- 239000001768 carboxy methyl cellulose Substances 0.000 claims description 4
- 239000000945 filler Substances 0.000 claims description 4
- 239000000314 lubricant Substances 0.000 claims description 4
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims description 4
- 239000002994 raw material Substances 0.000 claims description 4
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 claims description 4
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 claims description 4
- LNAZSHAWQACDHT-XIYTZBAFSA-N (2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2s,3r,4s,5r,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 claims description 2
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims description 2
- 239000004375 Dextrin Substances 0.000 claims description 2
- 229920001353 Dextrin Polymers 0.000 claims description 2
- 239000001856 Ethyl cellulose Substances 0.000 claims description 2
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 claims description 2
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 claims description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 2
- 229930195725 Mannitol Natural products 0.000 claims description 2
- 229920000168 Microcrystalline cellulose Polymers 0.000 claims description 2
- 229920000881 Modified starch Polymers 0.000 claims description 2
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 claims description 2
- 229920003081 Povidone K 30 Polymers 0.000 claims description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 2
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 claims description 2
- 239000004141 Sodium laurylsulphate Substances 0.000 claims description 2
- 239000001506 calcium phosphate Substances 0.000 claims description 2
- 229910000389 calcium phosphate Inorganic materials 0.000 claims description 2
- 235000011010 calcium phosphates Nutrition 0.000 claims description 2
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 claims description 2
- 238000004132 cross linking Methods 0.000 claims description 2
- 235000019425 dextrin Nutrition 0.000 claims description 2
- 239000003085 diluting agent Substances 0.000 claims description 2
- FPAFDBFIGPHWGO-UHFFFAOYSA-N dioxosilane;oxomagnesium;hydrate Chemical compound O.[Mg]=O.[Mg]=O.[Mg]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O FPAFDBFIGPHWGO-UHFFFAOYSA-N 0.000 claims description 2
- 239000007919 dispersible tablet Substances 0.000 claims description 2
- 239000003937 drug carrier Substances 0.000 claims description 2
- 239000003623 enhancer Substances 0.000 claims description 2
- 235000019325 ethyl cellulose Nutrition 0.000 claims description 2
- 229920001249 ethyl cellulose Polymers 0.000 claims description 2
- 239000008187 granular material Substances 0.000 claims description 2
- 239000001863 hydroxypropyl cellulose Substances 0.000 claims description 2
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 claims description 2
- 239000008101 lactose Substances 0.000 claims description 2
- 229940031703 low substituted hydroxypropyl cellulose Drugs 0.000 claims description 2
- 235000019359 magnesium stearate Nutrition 0.000 claims description 2
- 239000000594 mannitol Substances 0.000 claims description 2
- 235000010355 mannitol Nutrition 0.000 claims description 2
- 229920000609 methyl cellulose Polymers 0.000 claims description 2
- 239000001923 methylcellulose Substances 0.000 claims description 2
- 235000019813 microcrystalline cellulose Nutrition 0.000 claims description 2
- 239000008108 microcrystalline cellulose Substances 0.000 claims description 2
- 229940016286 microcrystalline cellulose Drugs 0.000 claims description 2
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 2
- 239000001253 polyvinylpolypyrrolidone Substances 0.000 claims description 2
- 229920000523 polyvinylpolypyrrolidone Polymers 0.000 claims description 2
- 235000013809 polyvinylpolypyrrolidone Nutrition 0.000 claims description 2
- 239000000741 silica gel Substances 0.000 claims description 2
- 229910002027 silica gel Inorganic materials 0.000 claims description 2
- 239000002002 slurry Substances 0.000 claims description 2
- 239000011734 sodium Substances 0.000 claims description 2
- 229910052708 sodium Inorganic materials 0.000 claims description 2
- 235000019333 sodium laurylsulphate Nutrition 0.000 claims description 2
- 235000000346 sugar Nutrition 0.000 claims description 2
- 239000004094 surface-active agent Substances 0.000 claims description 2
- 239000003826 tablet Substances 0.000 claims description 2
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 claims description 2
- 239000000080 wetting agent Substances 0.000 claims description 2
- 238000002474 experimental method Methods 0.000 abstract description 2
- 239000000463 material Substances 0.000 abstract description 2
- 238000000034 method Methods 0.000 abstract description 2
- 241000432824 Asparagus densiflorus Species 0.000 abstract 1
- 241000255789 Bombyx mori Species 0.000 abstract 1
- 235000002598 Inula helenium Nutrition 0.000 abstract 1
- 244000116484 Inula helenium Species 0.000 abstract 1
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 230000002195 synergetic effect Effects 0.000 abstract 1
- 231100000331 toxic Toxicity 0.000 abstract 1
- 230000002588 toxic effect Effects 0.000 abstract 1
- 230000001737 promoting effect Effects 0.000 description 11
- 210000000952 spleen Anatomy 0.000 description 11
- 210000001124 body fluid Anatomy 0.000 description 10
- 239000010839 body fluid Substances 0.000 description 10
- 239000000796 flavoring agent Substances 0.000 description 10
- 235000019634 flavors Nutrition 0.000 description 10
- 210000004072 lung Anatomy 0.000 description 10
- 208000002193 Pain Diseases 0.000 description 9
- 230000006870 function Effects 0.000 description 9
- 235000009508 confectionery Nutrition 0.000 description 6
- 210000004185 liver Anatomy 0.000 description 6
- 230000036407 pain Effects 0.000 description 6
- 210000002784 stomach Anatomy 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 5
- 239000000843 powder Substances 0.000 description 5
- 230000001954 sterilising effect Effects 0.000 description 5
- 230000001225 therapeutic effect Effects 0.000 description 5
- 239000008280 blood Substances 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 230000004087 circulation Effects 0.000 description 4
- 239000004615 ingredient Substances 0.000 description 4
- 238000007689 inspection Methods 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 206010011224 Cough Diseases 0.000 description 3
- 235000019789 appetite Nutrition 0.000 description 3
- 230000036528 appetite Effects 0.000 description 3
- 210000000481 breast Anatomy 0.000 description 3
- 210000001175 cerebrospinal fluid Anatomy 0.000 description 3
- 208000017574 dry cough Diseases 0.000 description 3
- 230000003203 everyday effect Effects 0.000 description 3
- 239000012567 medical material Substances 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 206010000087 Abdominal pain upper Diseases 0.000 description 2
- 206010002091 Anaesthesia Diseases 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- 206010010904 Convulsion Diseases 0.000 description 2
- 208000008454 Hyperhidrosis Diseases 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 230000037005 anaesthesia Effects 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 230000036461 convulsion Effects 0.000 description 2
- 206010061428 decreased appetite Diseases 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 210000000232 gallbladder Anatomy 0.000 description 2
- 210000002216 heart Anatomy 0.000 description 2
- 206010022437 insomnia Diseases 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 238000007619 statistical method Methods 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 230000035922 thirst Effects 0.000 description 2
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 206010013789 Dry throat Diseases 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 208000004929 Facial Paralysis Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 208000007101 Muscle Cramp Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 201000005702 Pertussis Diseases 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010057190 Respiratory tract infections Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 206010043458 Thirst Diseases 0.000 description 1
- 206010046306 Upper respiratory tract infection Diseases 0.000 description 1
- 208000036826 VIIth nerve paralysis Diseases 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 208000004711 cerebrospinal fluid leak Diseases 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 210000003792 cranial nerve Anatomy 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 206010013023 diphtheria Diseases 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 210000001951 dura mater Anatomy 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000037315 hyperhidrosis Effects 0.000 description 1
- 210000003026 hypopharynx Anatomy 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 210000001165 lymph node Anatomy 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 230000000306 recurrent effect Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 238000002636 symptomatic treatment Methods 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 239000002550 vasoactive agent Substances 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
组别 | 病例数 | 治愈(治愈率) | 有效(有效率) | 无效(无效率) | 总有效率 |
对照1组 | 50 | 15(30.0%) | 18(36.0%) | 17(34.0%) | 66.0% |
治疗组 | 50 | 40(80.0%) | 8(16.0%) | 2(4.0%) | 96.0% |
对照2组 | 50 | 16(32.0%) | 19(38.0%) | 15(30.0%) | 70.0% |
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510073675.3A CN104645149B (zh) | 2015-02-11 | 2015-02-11 | 一种治疗脊椎麻醉后头痛的中药组合物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510073675.3A CN104645149B (zh) | 2015-02-11 | 2015-02-11 | 一种治疗脊椎麻醉后头痛的中药组合物 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104645149A true CN104645149A (zh) | 2015-05-27 |
CN104645149B CN104645149B (zh) | 2016-03-09 |
Family
ID=53237118
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510073675.3A Active CN104645149B (zh) | 2015-02-11 | 2015-02-11 | 一种治疗脊椎麻醉后头痛的中药组合物 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104645149B (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105535468A (zh) * | 2016-01-26 | 2016-05-04 | 唐国萍 | 一种治疗脊椎麻醉后头痛的药物组合物 |
CN105796670A (zh) * | 2016-04-04 | 2016-07-27 | 孙爱华 | 一种治疗脊椎麻醉后头痛的中药组合物 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103920020A (zh) * | 2014-04-15 | 2014-07-16 | 韩世昌 | 一种治疗头痛的中药组合物及其制备方法 |
-
2015
- 2015-02-11 CN CN201510073675.3A patent/CN104645149B/zh active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103920020A (zh) * | 2014-04-15 | 2014-07-16 | 韩世昌 | 一种治疗头痛的中药组合物及其制备方法 |
Non-Patent Citations (2)
Title |
---|
卢启胜等: "腰麻后顽固性头痛治疗1例", 《医药产业资讯》 * |
李淑萍等: "补中益气汤加减治疗腰麻后低颅压综合征40例", 《新疆中医药》 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105535468A (zh) * | 2016-01-26 | 2016-05-04 | 唐国萍 | 一种治疗脊椎麻醉后头痛的药物组合物 |
CN105796670A (zh) * | 2016-04-04 | 2016-07-27 | 孙爱华 | 一种治疗脊椎麻醉后头痛的中药组合物 |
Also Published As
Publication number | Publication date |
---|---|
CN104645149B (zh) | 2016-03-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104784673B (zh) | 一种用于小儿腹泻的中药脐贴 | |
CN104667222A (zh) | 一种养胃健脾的中药 | |
CN103830749B (zh) | 一种胃肠造影剂 | |
CN104740437A (zh) | 一种治疗便秘的中药组合物及其制备方法 | |
CN104645149B (zh) | 一种治疗脊椎麻醉后头痛的中药组合物 | |
CN104524511A (zh) | 一种治疗小儿腹胀腹疼的药物及其制备方法 | |
CN106421432A (zh) | 一种治疗老年体虚症,延缓衰老的中药 | |
CN105435125A (zh) | 一种有益于上消化道肿瘤术后康复的中草药物 | |
CN101966297A (zh) | 治疗眩晕症的复方山茱萸人参叶汤 | |
CN104606663A (zh) | 一种促进产后恢复的中药 | |
CN107998366A (zh) | 一种适用于产后初期产妇催乳的中药组合物及其制备方法 | |
CN102895392B (zh) | 一种治疗十二指肠溃疡的中药 | |
CN102008634A (zh) | 防治糖尿病的中药保健茶 | |
CN102038889B (zh) | 治疗风湿性心脏病的中药 | |
CN104707035B (zh) | 一种治疗腰硬联合麻醉术后头痛的中药组合物 | |
CN103212010A (zh) | 治疗阳痿的中药组合物及其制备方法 | |
CN104666880A (zh) | 一种治疗产后缺乳的护理药物 | |
CN104906391A (zh) | 一种治疗气阴两虚型十二指肠溃疡的中药 | |
CN104998241A (zh) | 黄芪益气中药酒 | |
CN101732565B (zh) | 一种治疗消渴症的药物组合物 | |
CN115006506A (zh) | 一种滋补养肾的人参制剂及其制备方法 | |
CN103751367A (zh) | 一种治疗母马子宫蓄脓的中药组合物 | |
CN103751369A (zh) | 一种提高公马精液品质的中药组合物 | |
CN103751628A (zh) | 治疗婴幼儿腹泻的中药膏剂 | |
CN108714197A (zh) | 一种健胃消食片及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
C41 | Transfer of patent application or patent right or utility model | ||
CB03 | Change of inventor or designer information |
Inventor after: Wang Jiang Inventor after: Lin Lipeng Inventor before: Ren Xiaoju |
|
COR | Change of bibliographic data | ||
GR01 | Patent grant | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20160216 Address after: 276000 No. 211, Lanshan District, Linyi, Shandong, Jiefang Road Applicant after: Wang Jiang Applicant after: Lin Lipeng Address before: 276401 Yishui City, Linyi province Yishui County town of new lane, No. 18 Applicant before: Wang Guixia |
|
CP02 | Change in the address of a patent holder | ||
CP02 | Change in the address of a patent holder |
Address after: 223100 Hongze District Electronic Commerce Industrial Park in Huaian, Jiangsu Co-patentee after: Lin Lipeng Patentee after: Wang Jiang Address before: 276000 No. 211, Lanshan District, Linyi, Shandong, Jiefang Road Co-patentee before: Lin Lipeng Patentee before: Wang Jiang |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20201204 Address after: Room 507-508, Kezheng building, No.16, South Tiancheng Road, high speed rail new town, Xiangcheng District, Suzhou City, Jiangsu Province Patentee after: Suzhou juice Network Information Technology Co., Ltd Address before: 223100 Hongze District Electronic Commerce Industrial Park in Huaian, Jiangsu Patentee before: Wang Jiang Patentee before: Lin Lipeng |